Search Main menu LEO Pharma Therapeutic areas Products Research and Development Partnering Careers Section menu Organisation Mission & Vision Values LEO Code of Conduct Corporate responsibility Global presence Management The LEO Foundation LEO Pharma Research Foundation History Media Centre News News 2014 News 2013 News 2012 News 2011 News 2010 News 2009 Downloads Social media Financial figures LEO Pharma announces new CFO BALLERUP, Denmark, 8 September 2015 – LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, announces Anders Kronborg as EVP Global Finance, IT and Legal. Anders Kronborg will assume the position of Executive Vice President, Global Finance, IT and Legal, on 1 October 2015. Anders will join LEO Pharma’s new Executive Leadership Team, announced last week, and report directly to the CEO. Gitte Aabo, President and CEO of LEO Pharma, said: "I am delighted to welcome Anders to LEO Pharma’s executive leadership team. Anders brings with him a proven track record in financial management and extensive international experience. He will play a pivotal role in our ongoing efforts to help more people with skin diseases while continuing to run a competitive and sustainable business." Anders Kronborg has more than 20 years of senior financial management experience and comes from the position as Chief Operating Officer at Kinnevik Investment AB. Prior to this, Anders held roles as Chief Financial Officer at Metro International, Chief Financial Officer at the Danish commercial television station TV 2, Chief Financial Officer and Chief Executive Officer at the Danish business broadsheet Berlingske Tidende and Chief Financial Officer at DR, the Danish Broadcasting Corporation. Anders Kronborg, incoming EVP Global Finance, IT and Legal, said: "I look forward to joining LEO Pharma, a company that is truly committed to improving people’s lives around the world. With four launches this year and an intense search for global partnerships, this is a very exciting time for me to become part of LEO Pharma. I look forward to contributing towards the company’s continued success." Footer menu News Global presence Contact Terms of use Clinical Trial Disclosure LEO Pharma A/S Industriparken 55 DK-2750 Ballerup Danmark CVR No. 56759514 Tel +45 4494 5888 Fax +45 7226 3321